Medicare Enrolled
Dr. Dale Menard, MD
Neurology · Hickory, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Menard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Menard
Dr. Dale Menard is a neurology specialist in Hickory, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Menard performed 1,080 Medicare services across 893 unique beneficiaries.
Between the years covered by Open Payments, Dr. Menard received a total of $4,512 from 48 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Menard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in NC
$4,512 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,080
Medicare services
Top 18% in NC for neurology
893
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
418 | $79 | $255 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
140 | $72 | $231 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $60 | $171 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
67 | $123 | $486 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $118 | $481 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
55 | $178 | $689 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
50 | $45 | $148 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
39 | $85 | $263 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
30 | $274 | $845 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
29 | $195 | $799 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
26 | $73 | $370 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
24 | $90 | $254 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $120 | $392 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
19 | $43 | $115 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $92 | $326 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
13 | $32 | $258 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,512
Total received (2018-2024)
Avg $645/year across 7 years
Top 32% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,068 (90.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$443 (9.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,153
2023
$349
2022
$352
2021
$295
2020
$300
2019
$938
2018
$1,124
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$297
Teva Pharmaceuticals USA, Inc.
$175
ABBVIE INC.
$92
UCB, Inc.
$91
Novartis Pharmaceuticals Corporation
$69
JAZZ PHARMACEUTICALS INC.
$67
CSL Behring
$57
EMD Serono, Inc.
$47
ARGENX US, INC.
$44
Merz Pharmaceuticals, LLC
$31
Mallinckrodt Hospital Products Inc.
$30
Eisai Inc.
$28
Lundbeck LLC
$24
Avadel CNS Pharmaceuticals, LLC
$23
ACADIA Pharmaceuticals Inc
$22
Neurelis, Inc.
$19
TG Therapeutics, Inc.
$19
Lilly USA, LLC
$17
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$792
ABBVIE INC.
$406
PFIZER INC.
$385
Novartis Pharmaceuticals Corporation
$317
Adamas Pharmaceuticals, Inc.
$263
UCB, Inc.
$237
Amgen Inc.
$189
EMD Serono, Inc.
$138
Sunovion Pharmaceuticals Inc.
$125
Supernus Pharmaceuticals, Inc.
$115
Lundbeck LLC
$113
Genentech USA, Inc.
$107
GENZYME CORPORATION
$103
US WorldMeds, LLC
$91
JAZZ PHARMACEUTICALS INC.
$80
Allergan Inc.
$65
Avanir Pharmaceuticals, Inc.
$61
Greenwich Biosciences, Inc.
$61
DePuy Synthes Sales Inc.
$59
CSL Behring
$57
Biogen, Inc.
$54
Celgene Corporation
$50
Mallinckrodt Hospital Products Inc.
$48
Avadel CNS Pharmaceuticals, LLC
$45
ARGENX US, INC.
$44
Kyowa Kirin, Inc.
$44
Eisai Inc.
$42
Biohaven Pharmaceuticals, Inc.
$36
Janssen Pharmaceuticals, Inc
$33
Merz Pharmaceuticals, LLC
$31
E.R. Squibb & Sons, L.L.C.
$30
GE HEALTHCARE
$22
ACADIA Pharmaceuticals Inc
$22
Acorda Therapeutics, Inc
$22
AbbVie Inc.
$21
AQUESTIVE THERAPEUTICS, INC.
$20
Neurelis, Inc.
$19
LivaNova USA, Inc.
$19
TG Therapeutics, Inc.
$19
UPSHER-SMITH LABORATORIES LLC
$18
Lilly USA, LLC
$17
Integra LifeSciences Corporation
$17
Harmony Biosciences LLC
$14
Boston Scientific Corporation
$14
GlaxoSmithKline, LLC.
$12
Nalu Medical, Inc.
$12
Grifols USA, LLC
$12
Aprecia Pharmaceuticals, LLC
$11
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CODMAN CERTAS · CONDUIT · COPAXONE · DUOPA · EPIDIOLEX · Epidiolex · Fycompa · GEMTESA · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · KESIMPTA · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalu Neurostimulation System · Neupro · OCREVUS · ONFI · OXTELLAR XR · Ocrevus · Ponvory · QULIPTA · Rebif · Rystiggo · SPECTRA WAVEWRITER · SYMPAZAN · Spritam · TECFIDERA · TRELEGY ELLIPTA · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VIPER · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART HYTRULO · Vimpat · Wakix · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
8
Per 100K population
4.9
County median income
$64,544
Nearest hospital
CATAWBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Menard is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Menard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Menard performed 418 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Menard receive payments from pharmaceutical companies?
Yes. Dr. Menard received a total of $4,512 from 48 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menard's costs compare to other neurologists in Hickory?
Dr. Menard's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Hickory
Browse neurologists in Hickory ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology